Search results
Results from the WOW.Com Content Network
Article processing fees for journals indexed in the Directory of Open Access Journals (2019). Journals use a variety of ways to generate the income required to cover publishing costs (including editorial costs, any costs of administering the peer review system), such as subsidies from institutions [7] and subscriptions.
The journal was established in 1945 as the official journal of the Belgian Rheumatology Society and carried different titles before obtaining its current title in 1982. According to the Journal Citation Reports , the journal has a 2020 impact factor of 2.980.
The journal was established in 2006 by Future Medicine under the title Future Rheumatology. It became International Journal of Clinical Rheumatology in 2009 and is now published by Open Access Journals , an imprint of the Pulsus Group , which is on Jeffrey Beall 's list of "Potential, possible, or probable" predatory open-access publishers ...
Journal of Clinical Rheumatology is a peer reviewed and indexed medical journal in the field of clinical rheumatology, published by PANLAR, ...
Best Practice & Research: Clinical Rheumatology is a medical journal covering evidence-based medicine as applied to clinical practice of musculoskeletal conditions. It is aimed at clinical physicians and trainees, to help them keep up to date with current practice. Issues contain review articles with a practical bent. [1]
Does not accept clinical research articles that have been shared as preprints. Does not accept clinical research articles that have been shared as preprints. Does not accept clinical research articles that have been shared as preprints. [24] British Medical Journal Company: Not-for-profit servers (e.g. arXiv, bioRxiv, chemRxiv, medRxiv ...
Get AOL Mail for FREE! Manage your email like never before with travel, photo & document views. Personalize your inbox with themes & tabs. You've Got Mail!
Juniper Publishers was listed in Beall's List of potential predatory open-access publishers. [3] The company has been criticized for sending out email spam to scientists, calling for papers, [11] [12] [13] and for publishing at least one paper that violated research integrity (missing conflict of interest statement, missing informed consent by patients, and plagiarism).